{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:02:09Z","timestamp":1792458129136,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1053\/j.akdh.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:04:49Z","timestamp":1722243889000},"page":"374-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Updates on the Diagnosis and Management of Fibrillary Glomerulonephritis"],"prefix":"10.1053","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2603-360X","authenticated-orcid":false,"given":"Rose Mary","family":"Attieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2162-7542","authenticated-orcid":false,"given":"Yihe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8462-8043","authenticated-orcid":false,"given":"Jordan L.","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ki.1987.66","article-title":"Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features","volume":"31","author":"Alpers","year":"1987","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0272-6386(12)70138-5","article-title":"Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy","volume":"22","author":"Fogo","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features","volume":"63","author":"Rosenstock","year":"2003","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.akdh.2024.03.006_bib4","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2215\/CJN.03870319","article-title":"Fibrillary glomerulonephritis: clinicopathologic features and atypical cases from a multi-institutional cohort","volume":"14","author":"Andeen","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/j.ajkd.2013.03.031","article-title":"Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients","volume":"62","author":"Javaugue","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"9","key":"10.1053\/j.akdh.2024.03.006_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092102","article-title":"DNAJB9 is a Reliable immunohistochemical marker of fibrillary glomerulonephritis: evaluation of diagnostic efficacy in a large series of kidney biopsies","volume":"10","author":"Gambella","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000455390","article-title":"Clinical features and outcomes of a Racially diverse population with fibrillary glomerulonephritis","volume":"45","author":"Payan Schober","year":"2017","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s13730-022-00693-3","article-title":"A case of juvenile-onset fibrillary glomerulonephritis diagnosed by mass spectrometry and immunohistochemistry of DNAJB9","volume":"11","author":"Hattori","year":"2022","journal-title":"CEN Case Rep"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ndt\/gfg605","article-title":"Factor H deficiency and fibrillary glomerulopathy","volume":"19","author":"Bircan","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.akdh.2024.03.006_bib11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00467-008-0765-6","article-title":"A case of fibrillary glomerulonephritis with unusual IgM deposits and hypocomplementemia","volume":"23","author":"Shim","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"20","key":"10.1053\/j.akdh.2024.03.006_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026022","article-title":"Clinicopathologic features and treatment outcomes of patients with fibrillary glomerulonephritis: a case series","volume":"100","author":"Marinaki","year":"2021","journal-title":"Medicine"},{"key":"10.1053\/j.akdh.2024.03.006_bib13","first-page":"w13578","article-title":"Outcome of fibrillary glomerulonephritis","volume":"142","author":"Kalbermatter","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1053\/j.akdh.2024.03.006_bib14","article-title":"Fibrillary glomerulopathy with a high level of Myeloperoxidase-ANCA: a case report","volume":"2020","author":"Asakawa","year":"2020","journal-title":"Case Rep Nephrol Urol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000371802","article-title":"A case of fibrillary glomerulonephritis associated with thrombotic microangiopathy and anti-glomerular basement membrane antibody","volume":"5","author":"Momose","year":"2015","journal-title":"Nephron Extra"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ckj\/sfv126","article-title":"Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis","volume":"9","author":"Cheungpasitporn","year":"2016","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.006_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nefro.2021.03.009","article-title":"Fibrillary glomerulonephritis simulating glomerular basal antimembrane antibody disease with associated thrombotic microangiopathy and ANCAp","volume":"43","author":"S\u00e1nchez de la Nieta Garc\u00eda","year":"2023","journal-title":"Nefrologia"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2022.08.016","article-title":"Prognostic value of diffuse crescentic Lesions in fibrillary glomerulonephritis","volume":"81","author":"Javaugue","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11255-011-0073-0","article-title":"Fibrillary glomerulonephritis in a patient with systemic lupus erythematosus: a rare association","volume":"45","author":"Bhat","year":"2013","journal-title":"Int Urol Nephrol"},{"issue":"3-4","key":"10.1053\/j.akdh.2024.03.006_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3121\/cmr.2017.1371","article-title":"Fibrillary glomerulonephritis in primary Sjogren\u2019s syndrome: a rare cause of renal failure","volume":"15","author":"Sehgal","year":"2017","journal-title":"Clin Med Res"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ajkd.2018.03.017","article-title":"Congophilic fibrillary glomerulonephritis: a case series","volume":"72","author":"Alexander","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib23","article-title":"Fibrillary glomerulonephritis in a patient with Sjogren\u2019s syndrome","volume":"10","author":"Lodhi","year":"2018","journal-title":"Cureus"},{"issue":"12","key":"10.1053\/j.akdh.2024.03.006_bib24","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1681\/ASN.V9122244","article-title":"Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"9","author":"Markowitz","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2024.03.006_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/08860220802213062","article-title":"Fibrillary glomerulonephritis with hepatitis C viral infection and hypocomplementemia","volume":"30","author":"Ray","year":"2008","journal-title":"Ren Fail"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ndt\/12.1.210","article-title":"Fibrillary glomerulonephritis in a patient with adenocarcinoma of stomach","volume":"12","author":"Amir-Ansari","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000189016","article-title":"Rapidly progressive fibrillary glomerulonephritis and cutaneous T-cell lymphoma","volume":"73","author":"Navarro-Antolin","year":"1996","journal-title":"Nephron"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib28","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.clinre.2016.07.002","article-title":"Paraneoplastic fibrillary glomerulonephritis associated with intrahepatic cholangiocarcinoma: when diagnosis of a rare kidney disease leads to successful hepatic cancer treatment","volume":"41","author":"Normand","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1681\/ASN.2017050566","article-title":"DnaJ homolog subfamily B member 9 is a putative autoantigen in fibrillary GN","volume":"29","author":"Andeen","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.2017030306","article-title":"DnaJ heat shock protein family B member 9 is a Novel biomarker for fibrillary GN","volume":"29","author":"Dasari","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.ajkd.2020.04.015","article-title":"Immunoglobulin-negative DNAJB9-associated fibrillary glomerulonephritis: a report of 9 cases","volume":"77","author":"Said","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.006_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000520071","article-title":"Immunoglobulin-negative fibrillary glomerulonephritis Masked in diabetic nephropathy: a case report and discussion of a diagnostic Pitfall","volume":"2","author":"Lerner","year":"2022","journal-title":"Glomerular Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/01913120801937723","article-title":"Fibrillary glomerulonephritis with splenic involvement: a detailed autopsy study","volume":"32","author":"Satoskar","year":"2008","journal-title":"Ultrastruct Pathol"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.006_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/01913120390231672","article-title":"Fibrillary noncongophilic renal and extrarenal deposits: a report on 10 cases","volume":"27","author":"Hvala","year":"2003","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/ndt\/gfaa065","article-title":"Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study","volume":"36","author":"Erickson","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.006_bib37","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/ki.1992.433","article-title":"Clinical and pathologic features of fibrillary glomerulonephritis","volume":"42","author":"Iskandar","year":"1992","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.006_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/PAS.0000000000000605","article-title":"IgG subclass staining in Routine renal biopsy material","volume":"40","author":"Hemminger","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1681\/ASN.2007070757","article-title":"Fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"19","author":"Alpers","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.006_bib40","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1523-1755.2002.00628.x","article-title":"Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features","volume":"62","author":"Bridoux","year":"2002","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000468517","article-title":"A case of fibrillary glomerulonephritis with fibril deposition in the Arteriolar wall and a family history of renal disease","author":"Watanabe","year":"2017","journal-title":"Case Rep Nephrol Dial"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.006_bib42","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.ekir.2023.02.1093","article-title":"DNAJB9-Positive Tubulointerstitial-Predominant fibrillary nephritis","volume":"8","author":"Bourhis","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib43","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.ekir.2021.03.152","article-title":"POS-142 fibrillary glomerulonephritis cases CAPTURED IN the QUEENSLAND glomerulonephritis registry between 2000 to 2015: HISTOPATHOLOGICAL features, associated conditions and patient outcomes","volume":"6","author":"Doucet","year":"2021","journal-title":"Kidney International Reports"},{"issue":"9","key":"10.1053\/j.akdh.2024.03.006_bib44","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.34067\/KID.0002532020","article-title":"Fibrillary glomerulonephritis and DnaJ homolog subfamily B member 9 (DNAJB9)","volume":"1","author":"Klomjit","year":"2020","journal-title":"Kidney360"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.kint.2019.03.021","article-title":"New developments in the diagnosis of fibrillary glomerulonephritis","volume":"96","author":"Nasr","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib46","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ekir.2021.01.001","article-title":"Diagnostic approach to glomerulonephritis with fibrillar IgG deposits and light chain restriction","volume":"6","author":"Kudose","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.006_bib47","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.ajkd.2019.01.032","article-title":"Heavy chain fibrillary glomerulonephritis: a case report","volume":"74","author":"Nasr","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000525542","article-title":"Fibrillary glomerulonephritis, DNAJB9, and the unfolded protein response","volume":"2","author":"Andeen","year":"2022","journal-title":"Glomerular Dis"},{"key":"10.1053\/j.akdh.2024.03.006_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.880923","article-title":"Fibrillary glomerulonephritis and monoclonal gammopathy: potential diagnostic Challenges","volume":"12","author":"Da","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib50","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1053\/j.ajkd.2015.08.002","article-title":"AJKD Atlas of renal pathology: fibrillary glomerulonephritis","volume":"66","author":"Lusco","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.ajkd.2011.12.024","article-title":"Fibrillary glomerulonephritis presenting as rapidly progressive glomerulonephritis","volume":"60","author":"Sharma","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib52","doi-asserted-by":"crossref","first-page":"534","DOI":"10.5858\/2001-125-0534-ACOFGW","article-title":"A case of fibrillary glomerulonephritis with linear immunoglobulin G staining of the glomerular capillary walls","volume":"125","author":"Sethi","year":"2001","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.006_bib53","first-page":"413","article-title":"Fibrillary glomerulonephritis: presenting as crescentic glomerulonephritis causing rapidly progressive renal failure","volume":"4","author":"Nilajgi","year":"2011","journal-title":"NDT Plus"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5414\/CN108508","article-title":"Fibrillary glomerulonephritis masquerading as rapidly progressive glomerulonephritis with pseudo-linear glomerular basement membrane staining","volume":"84","author":"El-Husseini","year":"2015","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.006_bib55","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5414\/CN108667","article-title":"A case of mistaken identity: fibrillary glomerulonephritis masquerading as crescentic anti-glomerular basement membrane disease","volume":"85","author":"Thomas","year":"2016","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5414\/CN110653","article-title":"A rare case of diffuse crescents in fibrillary glomerulonephritis","volume":"97","author":"Choung","year":"2022","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.006_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0971-4065.200521","article-title":"Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis","volume":"27","author":"Shah","year":"2017","journal-title":"Indian J Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.006_bib58","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.kint.2019.01.024","article-title":"Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients","volume":"95","author":"Nasr","year":"2019","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.006_bib59","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.kint.2019.01.034","article-title":"Elevated serum concentrations of DNAJB9 in fibrillary glomerulonephritis: another step toward understanding a progressive disease","volume":"95","author":"Andeen","year":"2019","journal-title":"Kidney Int"},{"issue":"4S","key":"10.1053\/j.akdh.2024.03.006_bib60","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1053\/j.akdh.2024.03.006_bib61","author":"Yunes"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.006_bib62","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.4103\/1319-2442.352448","article-title":"Fibrillary glomerulonephritis with atypical immunoglobulin M deposits and hypocomplementemia revealed human Immunodeficiency virus infection","volume":"32","author":"Chalkia","year":"2021","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"Supplement_1","key":"10.1053\/j.akdh.2024.03.006_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfad063c_3041","article-title":"#3041 DNAJB9 positive primary fibrillary glomerulonephritis: treatment with corticosteroid pulses experience","volume":"38","author":"Oleas","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"28","key":"10.1053\/j.akdh.2024.03.006_bib64","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021101","article-title":"Successful treatment of a unique case of congophilic fibrillary glomerulonephritis: a case report","volume":"99","author":"Gandhi","year":"2020","journal-title":"Medicine"},{"issue":"suppl_1","key":"10.1053\/j.akdh.2024.03.006_bib65","doi-asserted-by":"crossref","first-page":"i401","DOI":"10.1093\/ndt\/gfy104.SP170","article-title":"SP170DEFINING Lung involvement in ANCA associated vasculitis patients using high resolution computerized tomography","volume":"33","author":"Crnogorac","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.006_bib66","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ckj\/sfy009","article-title":"Treatment of fibrillary glomerulonephritis with use of repository corticotropin injections","volume":"11","author":"Maroz","year":"2018","journal-title":"Clin Kidney J"},{"issue":"Suppl 5","key":"10.1053\/j.akdh.2024.03.006_bib67","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar3909","article-title":"Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity","volume":"14","author":"Mei","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1053\/j.akdh.2024.03.006_bib68","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","article-title":"Targeting B cells and plasma cells in autoimmune diseases","volume":"9","author":"Hofmann","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.006_bib69","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/ndt\/gfu189","article-title":"Rituximab treatment for fibrillary glomerulonephritis","volume":"29","author":"Hogan","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.006_bib70","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.ajkd.2008.07.011","article-title":"Rituximab treatment of fibrillary glomerulonephritis","volume":"52","author":"Collins","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.006_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000440815","article-title":"End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 Consecutive ANZDATA registry cases","volume":"42","author":"Mallett","year":"2015","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.006_bib72","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ckj\/sfx045","article-title":"Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of disease","volume":"10","author":"Sekulic","year":"2017","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.006_bib73","first-page":"159","article-title":"Outcome of renal transplantation in fibrillary glomerulonephritis","volume":"55","author":"Samaniego","year":"2001","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.006_bib74","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.ajkd.2020.01.018","article-title":"Recurrence of DNAJB9-positive fibrillary glomerulonephritis after kidney transplantation: a case series","volume":"76","author":"El","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.006_bib75","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4065\/mcp.2010.0337","article-title":"Prevalence of monoclonal gammopathy of undetermined significance: a systematic review","volume":"85","author":"Wadhera","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.006_bib76","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1016\/S0272-6386(98)70066-6","article-title":"Fibrillary glomerulonephritis in siblings","volume":"31","author":"Chan","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.akdh.2024.03.006_bib77","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/nep.12447","article-title":"Fibrillary glomerulonephritis: an apparent familial form?","volume":"20","author":"Ying","year":"2015","journal-title":"Nephrology"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.006_bib78","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ekir.2020.10.022","article-title":"Familial fibrillary glomerulonephritis in Living related kidney transplantation","volume":"6","author":"Jeyabalan","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.006_bib79","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ekir.2020.05.010","article-title":"Fibrillary glomerulonephritis is associated with HLA-DR7 and HLA-B35 antigens","volume":"5","author":"Andeen","year":"2020","journal-title":"Kidney Int Rep"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T05:06:50Z","timestamp":1722488810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813924000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2949813924000569"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2024.03.006","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on the Diagnosis and Management of Fibrillary Glomerulonephritis","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}